Skip to main content
TipRanks
Go Ultimate75% OFF

Vivo Opportunity, LLC Insider Profile

11 Followers

Vivo Opportunity, LLC, Ten Percent Owner at Mentari Therapeutics, holds 818.08K shares in Mentari Therapeutics (Ticker: MTRI), holds 4.46M shares in Soleno Therapeutics (Ticker: SLNO), holds 6.24M shares in Terns Pharmaceuticals (Ticker: TERN). Most recently, Vivo Opportunity, LLC Bought ― shares of Mentari Therapeutics on Jul 16, 2026 for an estimated value of $31.85K.

Vivo Opportunity, LLC's Trading History

MTRI
Mentari Therapeutics
Jul 16, 2026Ten Percent OwnerInformative Buy31.85K$14.32M
SLNO
Soleno Therapeutics
Mar 28, 2025―Informative Sell124.45M$236.33M
TERN
Terns Pharmaceuticals
Apr 03, 2024―Uninformative Sell2.80M$330.27M
SRRA
Sierra Oncology
Jul 01, 2022―Uninformative Sell183.12M$0.00

You May Also Like

Vivo Opportunity, LLC insider profile FAQ

What is the percentage of profitable transactions made by Vivo Opportunity, LLC?
The percentage of profitable transactions made by Vivo Opportunity, LLC is 73%.
What is the average return per transaction made by Vivo Opportunity, LLC?
The average return per transaction made by Vivo Opportunity, LLC is 17.80%.
What stocks does Vivo Opportunity, LLC hold?
Vivo Opportunity, LLC holds: MTRI, SLNO, SRRA, TERN stocks.
What was Vivo Opportunity, LLC’s latest transaction?
Vivo Opportunity, LLC’s latest transaction was an Informative Buy of $31.85K.
What was Vivo Opportunity, LLC's most profitable transaction?
Vivo Opportunity, LLC’s most profitable transaction was an Informative Buy of SLNO stock on October 4, 2023. The return on the trade was 87.30%.
What is Vivo Opportunity, LLC's role in Mentari Therapeutics?
Vivo Opportunity, LLC's role in Mentari Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.